Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A, Shioda Y, Imamura T, Kudo K, Kitoh T, Kawaguchi H, Goto H, Kosaka Y, Tsunematsu Y, Imashuku S; Japan LCH Study Group. Morimoto A, et al. Among authors: tsunematsu y. Int J Hematol. 2018 Aug;108(2):192-198. doi: 10.1007/s12185-018-2444-0. Epub 2018 Mar 28. Int J Hematol. 2018. PMID: 29594922 Clinical Trial.
Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A, Ikushima S, Kinugawa N, Ishii E, Kohdera U, Sako M, Fujimoto J, Bessho F, Horibe K, Tsunematsu Y, Imashuku S; Japan Langerhans Cell Histiocytosis Study Group. Morimoto A, et al. Among authors: tsunematsu y. Cancer. 2006 Aug 1;107(3):613-9. doi: 10.1002/cncr.21985. Cancer. 2006. PMID: 16804933 Free article. Clinical Trial.
Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A, Shioda Y, Imamura T, Kudo K, Kawaguchi H, Sakashita K, Yasui M, Koga Y, Kobayashi R, Ishii E, Fujimoto J, Horibe K, Bessho F, Tsunematsu Y, Imashuku S. Morimoto A, et al. Among authors: tsunematsu y. Int J Hematol. 2016 Jul;104(1):99-109. doi: 10.1007/s12185-016-1993-3. Epub 2016 Apr 4. Int J Hematol. 2016. PMID: 27040279
Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis.
Kudo K, Maeda M, Suzuki N, Kanegane H, Ohga S, Ishii E, Shioda Y, Imamura T, Imashuku S, Tsunematsu Y, Endo M, Shimada A, Koga Y, Hashii Y, Noguchi M, Inoue M, Tabuchi K, Morimoto A; Histiocytosis study group of the Japanese Society of Pediatric Hematology/Oncology. Kudo K, et al. Among authors: tsunematsu y. Int J Hematol. 2020 Jan;111(1):137-148. doi: 10.1007/s12185-019-02760-5. Epub 2019 Nov 22. Int J Hematol. 2020. PMID: 31758416 Review.
Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.
Imashuku S, Shioda Y, Kobayashi R, Hosoi G, Fujino H, Seto S, Wakita H, Oka A, Okazaki N, Fujita N, Minato T, Koike K, Tsunematsu Y, Morimoto A; Japan LCH Study Group (JLSG). Imashuku S, et al. Among authors: tsunematsu y. Haematologica. 2008 Apr;93(4):615-8. doi: 10.3324/haematol.11827. Epub 2008 Feb 20. Haematologica. 2008. PMID: 18287136 Free article.
VCR/AraC chemotherapy and ND-CNS-LCH.
Imashuku S, Shioda Y, Tsunematsu Y, Imamura T, Morimoto A; Japan LCH Study Group. Imashuku S, et al. Among authors: tsunematsu y. Pediatr Blood Cancer. 2010 Jul 15;55(1):215-6. doi: 10.1002/pbc.22478. Pediatr Blood Cancer. 2010. PMID: 20310001 No abstract available.
188 results